What IDDI does

IDDI (International Drug Development Institute) is a privately held clinical data science partner founded in 1991 by Marc Buyse, ScD, headquartered in Ottignies-Louvain-la-Neuve, Belgium, with a US office in Raleigh, NC (established 2014). The firm specializes in premium biostatistics, clinical data management, strategic consulting, and eClinical technology services for pharmaceutical, biotechnology, medical device, and academic research sponsors globally, with deep therapeutic concentration in oncology (880+ trials supported), ophthalmology (180+), CNS (65+), cardiology, infectious disease, and rare diseases. Its core service portfolio spans Advanced Biostatistical Analysis, Independent Data Monitoring Committee (IDMC) services (1,000+ meetings supported), SDTM/ADaM data standards implementation as a CDISC Registered Solutions Provider, PK/PD analysis, and regulatory statistics consulting for FDA/EMA submissions.

Underlying its service offering is a proprietary technology stack including ID-Spectackle (a graphical interface for ADaM specification preparation and Define-XML generation), ID-Code (a web-based MedDRA/WHODrug medical coding tool), and the patented Generalized Pairwise Comparisons (GPC) methodology that underpins the One2Treat spinoff. The firm integrates with major eClinical platforms (Medidata Rave, Veeva EDC, AB Cube Marvin, Merative, Zelta for EDC; Suvoda IRT and Mentor RTSM for randomization and supply management), positioning itself as an implementation and statistical analysis partner to platform vendors rather than a competing platform vendor.

IDDI operates a project-based professional services revenue model with multi-year contracts covering clinical trial design through regulatory submission, supporting 350+ clients worldwide and reporting an 80% repeat business rate. Go-to-market is enterprise field sales augmented by content marketing, industry conference presence (SCOPE, SCDM, OCT, PSI), webinars, and a thought leadership publishing engine (1,000+ scientific publications). The firm has productized its R&D twice via spinoffs: CluePoints (2012) for central statistical monitoring and One2Treat (2024) for patient-centric Net Treatment Benefit analysis, both arising from internal methodology research. Revenue is not publicly disclosed; the firm has no disclosed institutional funding rounds and operates across approximately 101-250 employees.

Name

IDDI

Legal name

International Drug Development Institute (IDDI, s.a.)

Website

https://iddi.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

101–250 employees

Short description

IDDI is a privately held Belgian-founded clinical data science partner (est. 1991) providing premium biostatistics, clinical data management, regulatory statistics, and eClinical technology services to pharmaceutical, biotech, medical device, and academic sponsors across oncology, ophthalmology, CNS, and rare disease trials worldwide.

Ownership category

akta.pro rank

Product category

Clinical Research Services (CRO / Clinical Data Science)

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690), Computer Systems Design and Related Services (54151)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO)

akta.pro secondary industries

Electronic Data Capture (EDC) Platforms (HLACAOAA), Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS) (HLACAOAC)

Keywords

• Clinical biostatistics services
• Clinical data management
• EClinical technologies
• Regulatory statistics consulting
• CDISC data standards

Headquarters

HQ city

Louvain-la-neuve

HQ country

Belgium

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Professional Services - Clinical Data Science: IDDI generates revenue through providing expert clinical data science services including biostatistics, clinical data management, strategic consulting, and eClinical technologies. Services are delivered through dedicated project teams with expertise across therapeutic areas. The company operates on a project-based engagement model, typically involving multi-year contracts for clinical trial support from design through regulatory submission.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

IDDI provides expert clinical data science services for pharmaceutical, biotechnology, and medical device sponsors, covering biostatistics (advanced analysis, IDMC interim analysis, ADaM/SDTM data standards, PK/PD), end-to-end clinical data management (EDC, medical coding, database lock), and strategic consulting for clinical trial design and regulatory submissions. Services are delivered through dedicated project teams and complemented by proprietary eClinical tools (ID-Spectackle, ID-Code) and partner-integrated platforms (Medidata Rave, Suvoda IRT, Mentor RTSM).

Product overview

IDDI is a clinical data science company offering a unified portfolio of premium biostatistics, clinical data management, and strategic consulting services, enhanced by eClinical technologies. The core offering consists of Biostatistics Services (including Advanced Biostatistical Analysis, IDMC Services, PK/PD, and ADaM implementation via proprietary tool ID-Spectackle) and Clinical Data Management (including SDTM standards implementation). These are complemented by Strategic Consulting (covering study design and regulatory statistics) and eClinical Technologies including Electronic Data Capture (using Marvin, Medidata Rave, Veeva, Zelta, Merative platforms), Randomization and Trial Supply Management (using Suvoda IRT and Mentor RTSM), and patient-centric solutions through spinoff brand One2Treat. IDDI has also spun off CluePoints for central statistical monitoring. The company positions itself as a specialized partner focused exclusively on clinical data science, differentiating from full-service CROs.

Differentiator

Problem solved

Functional benefit

Products and services

• Biostatistics Services Core clinical biostatistics services supporting every stage of clinical trials, including advanced biostatistical analysis, interim analysis with Independent Data Monitoring Committees (IDMC), ADaM data standards implementation, and PK/PD analysis for pharmaceutical, biotech, and medical device sponsors.
• Advanced Biostatistical Analysis Comprehensive biostatistical analysis services covering trial design, setup, conduct, analysis, and reporting, including innovative trial design, statistical analysis plan creation, SAS programming, interim analyses, and FDA/EMA submission support.
• Independent Data Monitoring Committee (IDMC) Services Comprehensive IDMC services including Statistical Data Analysis Center (SDAC) services, IDMC Charter development, simulation-based forecasting, interim efficacy and futility analysis, and regular DMC meeting management, having supported over 1,000 IDMC meetings.
• PK/PD Services Pharmacokinetics and pharmacodynamics services linking drug exposure to clinical outcomes, supporting safety differentiation, developing precision dosing strategies, and strengthening regulatory strategy.
• Clinical Data Management End-to-end clinical data management services from database setup through cleaning, reporting, and database lock, including SDTM data standards implementation, medical coding, and EDC support.
• SDTM Data Standards Implementation CDISC SDTM data standards implementation services delivered as a CDISC Registered Provider, including mapping to SDTM standards, annotated CRFs, define.xml files, validation, and ISS/ISE summaries, with 100+ SDTM studies experience.
• Strategic Consulting Strategic consulting for clinical trials covering study design, regulatory statistics, clinical development plan optimization, and regulatory support for IND/NDA submissions, pediatric exclusivity, orphan drug designation, and IVD/medical device clearances.
• Regulatory Statistics Regulatory statistics services ensuring statistical methods are scientifically sound and meet regulatory requirements, including adaptive trial designs, dose optimization, sequential testing, and real-world evidence use.
• Electronic Data Capture (EDC) Services Electronic data capture services implementing over 160 EDC clinical trials using platforms including Marvin (AB Cube), Medidata Rave, Zelta, Merative, and Veeva, with real-time data capture, automated eCRF setup, and CDISC compliance.
• Randomization and Trial Supply Management (RTSM) Randomization and trial supply management services using Suvoda IRT software and Mentor RTSM platform, ensuring scientific integrity and operational efficiency with configurable and customizable end-to-end randomization and drug logistics.

Quantifiable outcome

• 80% repeat business rate indicating high client satisfaction
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

Feature4 records

Partnerships

20 partnerships are on record, tiered major, minor and core.

• One2TreatmajorStrategic or Co-development Partner · 1 July 2024One2Treat was spun off from IDDI in July 2024 as a company dedicated to patient-centric clinical trial solutions. The company develops methods and software enabling holistic evaluation of treatment effects by integrating patient-relevant outcomes into comprehensive Net Treatment Benefit assessments.
• CluePointsmajorStrategic or Co-development Partner · 1 January 2012CluePoints was spun off from IDDI in early 2012, dedicated to central statistical monitoring applied to clinical trials. Offers unique Central Statistical Monitoring software for detecting heterogeneity of data across investigational centers and creating quality labels for clinical trial data.
• Clinical Trials For AllminorStrategic or Co-development PartnerPartnership addressing the problem of patient participation in clinical trials, supporting improved patient engagement and diversity in clinical research.
• Curare ConsultingminorImplementation/ SI/ Consulting PartnerPartnership for Clinical Pharmacology Experts services, providing complementary expertise for clinical development programs.
• ECCRTminorImplementation/ SI/ Consulting PartnerPartnership for GCP Training Expert services, ensuring staff training and compliance support for clinical trials.
• MedidatacoreTechnology or IntegrationPartnership for Electronic Data Capture using Rave EDC system. IDDI implements and manages Medidata Rave EDC for clinical trials, offering integrated eClinical technology services.
• Partner 4 HealthminorImplementation/ SI/ Consulting PartnerPartnership for Medical Writing services, providing comprehensive documentation support for clinical trials.
• RLM ConsultingminorImplementation/ SI/ Consulting PartnerPartnership for Regulatory Affairs and Early Development consulting services.
• SuvodacoreTechnology or IntegrationPartnership for Randomization and Trial Supply Management (RTSM) using Suvoda IRT software, providing centralized control for patient and drug logistics in clinical trials.
• TransPerfectminorImplementation/ SI/ Consulting PartnerPartnership for Medical Writing services, providing comprehensive documentation and translation support.
• VCLSminorImplementation/ SI/ Consulting PartnerPartnership for Regulatory Strategy and Access to Market consulting services.
• VeristatminorImplementation/ SI/ Consulting PartnerPartnership for Medical Writing services, providing comprehensive documentation support.
• Bristol Myers SquibbmajorStrategic or Co-development PartnerDevelopment partner in the BENEFIT (Biostatistical Estimation of Net Effects for Individualization of Therapy) research project, developing Generalized Pairwise Comparisons (GPC) methodology for personalized medicine.
• EORTCmajorStrategic or Co-development PartnerEuropean Organization for Research and Treatment of Cancer partnered with IDDI on BENEFIT research project for GPC methodology development.
• UCL (Université Catholique de Louvain)majorStrategic or Co-development PartnerAcademic partner in BENEFIT research project, collaborating on Generalized Pairwise Comparisons methodology for personalized medicine.
• University Hospital and Cancer Center of LyonmajorStrategic or Co-development PartnerClinical partner in BENEFIT research project contributing to GPC methodology development for personalized therapy.
• BiowinmajorStrategic or Co-development PartnerWalloon cluster of biotechnology partnered with IDDI on TREATBEST project for analytical and clinical validation of in vitro diagnostic kit for triple negative breast cancer, and SMART project for Statistical Monitoring Applied to Research Trials.
• PamgeneminorStrategic or Co-development PartnerPartner in BRAVO (Biomarker Retrospective Analysis for Validation Optimization) project granted by EuroTransBio.
• VUMC (VU University Medical Center)minorStrategic or Co-development PartnerPartner in BRAVO project for biomarker validation optimization.
• I-BiostatminorStrategic or Co-development PartnerPartner in BRAVO project for biomarker validation methodology.

Scale indicators14 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Cytel: Specialized biostatistics and statistical software CRO offering biostatistics services, statistical programming, and clinical data analytics across oncology and rare diseases — directly comparable as a specialist competing in the same clinical data science niche as IDDI.
• Rho: Clinical research organization with strong biostatistics, clinical data management, and regulatory affairs offerings, including CDISC expertise — directly comparable in service mix and therapeutic focus on rare diseases and pediatrics.
• Statistics Collaborative: Specialized biostatistics consulting firm supporting pharmaceutical and biotech sponsors across clinical trial design and analysis — comparable size and specialty positioning, and notably the prior employer of IDDI COO Tara Kervin.

Emerging players

• CluePoints: IDDI's 2012 spinoff providing central statistical monitoring and risk-based quality management for clinical trials — adjacent competitor now operating independently in a slice of IDDI's data quality domain.
• BioStat Solutions: Specialized biostatistics and statistical programming services firm focused on FDA submissions and CDISC-compliant deliverables — partial overlap with IDDI's CDM and biostatistics practices.

Broad incumbents

• IQVIA: Largest full-service CRO offering biostatistics, clinical data management, EDC (Rave) and consulting at global scale — broad incumbent whose offerings overlap IDDI's core services but as part of a much wider portfolio.
• Parexel International: Global full-service CRO with biostatistics, data management and regulatory consulting practices comparable to IDDI but embedded in a much larger end-to-end drug development offering.
• ICON plc: Major full-service CRO with extensive biostatistics, EDC and clinical data management services — broad incumbent whose suite overlaps with IDDI's specialty offerings.

Others

• Medidata Solutions: Provider of the Medidata Rave EDC platform, a core technology IDDI implements and supports; functions as a partner-platform provider rather than a direct services competitor.
• Veeva Systems: Provider of Veeva Vault EDC and clinical suite technology that IDDI configures and manages for sponsors — adjacent enabling technology vendor in IDDI's clinical technology ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC4Ef4_yf5Wurco-2YiVguqg
• Facebookfacebook.com/profile.php?id=100052568724769
• LinkedInlinkedin.com/company/iddi
• Xx.com/IDDI_Official

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDDI